BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 2679278)

  • 1. [Partial lipodystrophy and membranoproliferative glomerulonephritis. Apropos of a case].
    Martínez Debora MJ; Vázquez Martul M; Ecija Peiró JL; González Pérez J; Lirio Rodríguez J; González Mediero I
    An Esp Pediatr; 1989 Jun; 30(6):499-502. PubMed ID: 2679278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
    Habib R; Lévy M; Gubler MC; Broyer M; Habib M
    Arch Fr Pediatr; 1977; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical significance of partial lipoatrophy and C3 hypocomplementaemia: a report of two cases.
    Wayte J; Bird G; Wilkinson JD
    Clin Exp Dermatol; 1996 Mar; 21(2):131-4. PubMed ID: 8759201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C3 nephritic factor and SLE: report of four cases and review of the literature.
    Walport MJ; Davies KA; Botto M; Naughton MA; Isenberg DA; Biasi D; Powell RJ; Cheung NT; Struthers GR
    QJM; 1994 Oct; 87(10):609-15. PubMed ID: 7987656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of a benign subtype of dense deposit disease: comparison with the progressive form of this disease.
    Klein M; Poucell S; Arbus GS; McGraw M; Rance CP; Yoon SJ; Baumal R
    Clin Nephrol; 1983 Oct; 20(4):163-71. PubMed ID: 6556977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Partial lipodystrophy (cephalothoracic type) with asymptomatic dense deposit disease (author's transl)].
    Houssin A; Saint-André JP; Buzelin F; Guenel J
    Ann Med Interne (Paris); 1981; 132(1):44-7. PubMed ID: 7224470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
    Lévy M; Sich M; Habib R
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
    Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial incidence of C3 nephritic factor, partial lipodystrophy and membranoproliferative glomerulonephritis.
    Power DA; Ng YC; Simpson JG
    Q J Med; 1990 Apr; 75(276):387-98. PubMed ID: 2385743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
    Ng YC; Peters DK
    Clin Exp Immunol; 1986 Aug; 65(2):450-7. PubMed ID: 3641695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial lipodystrophy and glomerulonephritis without complement activation.
    Mery JP; Kourilsky O; Morel-Maroger L; Adam C
    N Engl J Med; 1978 May; 298(18):1034. PubMed ID: 643001
    [No Abstract]   [Full Text] [Related]  

  • 12. Rare case of spot diagnosis of nephrotic syndrome in a Saudi male.
    Askar A; Mushtaq F; Al Shuaibi F; Mustafa M; Bappu A
    Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):1003-7. PubMed ID: 21912033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eculizumab therapy in a patient with dense-deposit disease associated with partial lipodystropy.
    Ozkaya O; Nalcacioglu H; Tekcan D; Genc G; Meydan BC; Ozdemir BH; Baysal MK; Keceligil HT
    Pediatr Nephrol; 2014 Jul; 29(7):1283-7. PubMed ID: 24464478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Partial lipodystrophy in two HLA identical sisters with hypocomplementemia and nephropathy].
    Peces R
    Nefrologia; 2002; 22(6):564-9. PubMed ID: 12516290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complement abnormalities of lipodystrophy.
    Sissons JG; West RJ; Fallows J; Williams DG; Boucher BJ; Amos N; Peters DK
    N Engl J Med; 1976 Feb; 294(9):461-5. PubMed ID: 1246331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Production of C3 nephritic factor by cultured lymphocytes derived from glomerulonephritic patients].
    Yamada A; Ohi H; Hatano M
    Nihon Jinzo Gakkai Shi; 1990 Apr; 32(4):373-8. PubMed ID: 2376910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term evolution of patients with isolated C3 mesangial glomerulonephritis.
    Calls Ginesta J; Almirall J; Torras A; Darnell A; Revert L
    Clin Nephrol; 1995 Apr; 43(4):221-5. PubMed ID: 7606875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of C3 nephritic factor by cultured lymphocytes derived from a patient with partial lipodystrophy.
    Yamada A; Ohi H; Okano K; Watanabe S; Seki M; Hatano M; Koitabashi Y
    J Clin Lab Immunol; 1988 Sep; 27(1):35-7. PubMed ID: 3251045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recurrence of intramembraneous glomerulonephritis in 2 consecutive kidney transplantations].
    Schmidt P; Kerjaschki D; Syré G; Pils P; Kopsa H; Zazgornik J; Balcke P; Stemberger H
    Schweiz Med Wochenschr; 1978 May; 108(21):781-8. PubMed ID: 349682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Partial lipodystrophy with osteomyelitis (author's transl)].
    Böhles H; Kövary PM
    Klin Padiatr; 1982 Mar; 194(2):124-7. PubMed ID: 7098372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.